Maternal and fetal sequelae of anticoagulation during pregnancy.
about
Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal periodProphylaxis for venous thromboembolic disease in pregnancy and the early postnatal periodIdentification of two novel transmembrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissuesBiochemical characterization of arylsulfatase E and functional analysis of mutations found in patients with X-linked chondrodysplasia punctataVTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesThe health benefits of vitamin KPeriostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cellsIdentification of a Drosophila vitamin K-dependent gamma-glutamyl carboxylase.Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy.Management of venous thromboembolism during pregnancy.Antiphospholipid antibodies and recurrent pregnancy loss.Pitfalls in the Use of Anticoagulants.Ultrastructural and biochemical aspects of matrix vesicle-mediated mineralizationLong-term anticoagulation. Indications and management.Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves.Clinical teratology: identifying teratogenic risks in humans.Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb.Cardiac valve prostheses, anticoagulation, and pregnancy.Thromboembolism during pregnancy. Risks, challenges, and recommendations.AnticoagulantsComplications of anticoagulant therapy.Coronary angioplasty in pregnancy.Valve prostheses and pregnancyDeep vein thrombosis: a clinical review.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol.Prescribing in pregnancy. Identifying abnormalities.Ischemic Stroke during Pregnancy and PuerperiumLong-term outlook in treated congenital heart disease.Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis.Oral heparin: status reviewTeratogen-induced limb defects.Maternal-fetal and neonatal pharmacogenomics: a review of current literature.Monitoring of low molecular weight heparin in pregnancy.Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives.Anticoagulation in pregnant women with mechanical heart valve prostheses.Foetal warfarin syndrome--a complex airway problem. Case report and review of the literature.Environmental teratogens.Warfarin-Associated Diaphragmatic Hernia: An Unusual Diagnosis.Fatal hemorrhage in mice lacking gamma-glutamyl carboxylase.
P2860
Q24200433-2465B3D1-E742-42AF-8BCE-9D5570D92014Q24235476-76B88BB0-9B68-415A-A3F8-BCBBCED064B1Q24290813-1712D06A-0439-4766-A220-E5E7491B55A4Q24538789-61AF0F13-8B29-420A-87C8-02E51CF5806EQ24632982-31DAE9B8-6BFC-4DB5-AEFB-4F349243E7FCQ26782816-74556EC3-289D-4CCD-837B-4785EBC24D4FQ28116256-D16535D9-B998-4469-A59A-690D04DAFF80Q33180094-F6772DFC-B619-4EE1-BFD8-58C3412668ABQ33334262-04042855-A97E-4205-B28D-D6CE4A5C9ABCQ33349065-6A4142FD-C120-4DB2-924E-E2058CC89E26Q33416855-36573C54-135C-4D9A-BDC6-19BE8E382841Q33441493-BA4E1E3E-A8CC-455A-ACDE-58FCBB3C183BQ33603761-D70C8F18-E6B7-4582-AA51-EB83C65A31BCQ33617257-B0FAF130-EFA2-4CBB-98D7-2A545177DF6CQ33758553-54F2A5C2-8434-48F8-9272-1A3A69DF6709Q33832749-42CB52D6-4DA2-4AEC-BE0C-86B1FA8D80B0Q33882034-5ECE02A0-A115-4B4D-BB85-C547314ACDD6Q34036734-344C0CB6-5EF1-4E2D-96C4-FD8A51264E06Q34054485-99F5B8E8-DD33-4081-ABD4-B8D5ECFCA6A3Q34068676-836BED31-FE75-406E-8206-12B49E10C6B0Q34108362-123DB9D8-1DEA-4B3C-8FC8-7B3970EA2626Q34117365-B90DE6EA-7082-4CE3-A674-FB3DE4F66D85Q34118406-81C3032A-8223-4B4B-B669-A976C9C91812Q34144439-BD8A6718-DB27-49B2-A3EA-DCBD79668393Q34252907-8437D13B-8EC7-480D-8687-ADB05C638D70Q34286102-677DAAD6-3C6A-4E0A-9514-B0E0024E0824Q34290528-EB2D96C4-8ED4-4CFA-B7FE-32C4D2ADA2C7Q34572665-42076063-9A53-4C45-91AC-B08253F998C4Q34799470-8A5F575C-1480-4E32-BBE8-4E42CF6C3F93Q34811304-49C87F5D-A50E-48C9-90DE-034A8B68A762Q34893606-46C37546-47B5-4F74-BC54-E4B933D30A66Q34926892-FB7ED450-77D1-4AA8-84AB-FB307A13A5A5Q34994866-19591538-3AE2-463B-9A72-E268C9EF1709Q35080331-54697B84-06F1-43C9-AE39-39AD265A9F98Q35199460-195764BB-5479-49CB-8CB6-34DED75E1298Q35372733-D1EED55C-B14F-4E7F-8674-2DE1609023F1Q35661749-2FC2E4B4-6E3D-4386-8ABC-C8D694E30788Q35662122-2FBC62BD-F47F-4F9E-8367-9457BC285C2BQ35675859-A6A4980F-54D8-4CCC-BA4E-FD6C90EEC582Q35839891-70B4CB80-DA96-4018-B54A-6A6066692409
P2860
Maternal and fetal sequelae of anticoagulation during pregnancy.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Maternal and fetal sequelae of anticoagulation during pregnancy.
@en
type
label
Maternal and fetal sequelae of anticoagulation during pregnancy.
@en
prefLabel
Maternal and fetal sequelae of anticoagulation during pregnancy.
@en
P2093
P1476
Maternal and fetal sequelae of anticoagulation during pregnancy.
@en
P2093
P304
P356
10.1016/0002-9343(80)90181-3
P407
P577
1980-01-01T00:00:00Z